Azevedo, R. S., Kantarjian, H., Senapati, J., Bouligny, I., Bazinet, A., Jen, W., Alousi, A., Popat, U., Shpall, E., Pemmaraju, N., Jain, N., Kugler, E., Belgarde, C., Jabbour, E., Garcia-Manero, G., DiNardo, C., Daver, N., Ravandi, F., Kadia, T. (2025). Cladribine, cytarabine, and venetoclax-based regimens are associated with durable remissions in patients (pts) with newly diagnosed Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation. Blood. https://doi.org/10.1182/blood-2025-1630